Cover Image

Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials

Background: This review aimed to conduct an indirect comparison using a Bayesian network meta-analysis of randomized controlled trials (RCTs) to compare the efficacy and safety of delafloxacin versus other single antibiotic regimens for the empiric treatment of Acute Bacterial Skin and Skin Structur...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abdullah A. Alhifany (Author), Nisrin Bifari (Author), Yasser Alatawi (Author), Saad U. Malik (Author), Thamer A. Almangour (Author), Ali F. Altebainawi (Author), Thamir M. Alshammari (Author), Amal F. Alotaibi (Author), Ahmad J. Mahrous (Author), Fahad S. Alshehri (Author), Ejaz Cheema (Author)
Format:	Book
Published:	Elsevier, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
by: April Barbour, et al.
Published: (2010)

Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort
by: Daniel Arnés García, et al.
Published: (2023)

The efficacy and adverse events of delafloxacin for treating acute bacterial skin and skin structure infections: A systematic review and meta-analysis
by: Syed Bilal Tanvir, et al.
Published: (2020)

Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
by: Goodman JJ, et al.
Published: (2012)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
by: Mpenge MA, et al.
Published: (2015)

Assessment of Caspofungin use at a Tertiary Teaching Hospital and compliance with IDSA guidelines and FDA labelings
by: Abrar F. Alshehri, et al.
Published: (2022)

In Vitro Activity of Ceftaroline, Linezolid, and Tigecycline against Staphylococcus aureus and Streptococcus pneumoniae by Infection Site in the Africa/Middle East Region, 2014-17
by: I Morrissey, et al.
Published: (2020)

Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
by: Wanda C Reygaert
Published: (2010)

Updated Review on Clinically-Relevant Properties of Delafloxacin
by: Adrien Turban, et al.
Published: (2023)

Delafloxacin: design, development and potential place in therapy
by: Candel FJ, et al.
Published: (2017)

Ceftobiprole Perspective: Current and Potential Future Indications
by: Tommaso Lupia, et al.
Published: (2021)

Ceftobiprole for the treatment of pneumonia: a European perspective
by: Liapikou A, et al.
Published: (2015)

Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
by: Béla Kocsis, et al.
Published: (2021)

In Silico Study of Ceftaroline's Molecular Properties
by: Elso Manuel Cruz Cruz, et al.
Published: (2011)

In Silico Study of Ceftaroline's Molecular Properties
by: Elso Manuel Cruz Cruz, et al.
Published: (2011)

Unraveling medication errors in enteral tube administration: A cross-sectional study in geriatric patients receiving home health care
by: Nisrin Bifari, et al.
Published: (2024)

Energy drinks and population health: consumption pattern and adverse effects among Saudi population
by: Gehad M. Subaiea, et al.
Published: (2019)

Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example
by: Thamir M. Alshammari, et al.
Published: (2020)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
by: Phylinda L.S. Chan, et al.
Published: (2021)

Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: A retrospective matched cohort study
by: Thamer A. Almangour, et al.
Published: (2020)

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019-2020
by: Alona Kuraieva, et al.
Published: (2023)

Association between graduates' factors and success rate on the Saudi Pharmacist Licensure Examination: A single-Institution cross-sectional study
by: Abdullah A. Alhifany, et al.
Published: (2020)

Association of medication storage with diabetes control: A cross-sectional study from Saudi Arabia
by: Ali F. Altebainawi, et al.
Published: (2020)

Development of Lipomer Nanoparticles for the Enhancement of <i>Drug</i> Release, Anti-Microbial Activity and Bioavailability of Delafloxacin
by: Md. Khalid Anwer, et al.
Published: (2020)

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
by: Liu J, et al.
Published: (2021)

Calculation of the molecular properties of five cephalosporins: cephradine, cephalexin, cefadroxil, cefprozil and ceftobiprole
by: Elso Manuel Cruz Cruz, et al.
Published: (2010)

Calculation of the molecular properties of five cephalosporins: cephradine, cephalexin, cefadroxil, cefprozil and ceftobiprole
by: Elso Manuel Cruz Cruz, et al.
Published: (2010)

Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections
by: Claire Duployez, et al.
Published: (2020)

Assessing Galleria mellonella as a preliminary model for systemic Staphylococcus aureus infection: Evaluating the efficacy and impact of vancomycin and Nigella sativa oil on gut microbiota
by: Faris S. Alnezary, et al.
Published: (2023)

Adherence to evidence-based guidelines for the management of pneumonia in a tertiary teaching hospital in Riyadh
by: Mohammed Alessa, et al.
Published: (2023)

Population Pharmacokinetics of Tigecycline: A Systematic Review
by: Zhou CC, et al.
Published: (2022)

Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort
by: Carmen Hidalgo-Tenorio, et al.
Published: (2023)

Health Literacy, Perceived Threat, and Posttraumatic Stress Disorder During the COVID-19 Pandemic in Saudi Arabia
by: Alatawi Y, et al.
Published: (2020)

Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
by: Mark M. Hahn, et al.
Published: (2023)

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database
by: Ali F. Altebainawi, et al.
Published: (2023)

Are countries' precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide
by: Thamir M. Alshammari, et al.
Published: (2021)

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
by: Maggiore C, et al.
Published: (2015)

Prevalence of post-traumatic stress disorder during the COVID-19 pandemic in Saudi Arabia
by: Fahad S. Alshehri, et al.
Published: (2020)

Ampicillin and Ceftobiprole Combination for the Treatment of <i>Enterococcus faecalis</i> Invasive Infections: "The Times They Are A-Changin"
by: Simone Giuliano, et al.
Published: (2023)